Presentation Slides

Displaying 1 - 11 out of 11 topics found with matching tool types

    Brain Injury and Brain Death

  1. Practice guideline: Reducing brain injury after cardiopulmonary resuscitation

    May 2017

  2. Summary of Evidence-based Guideline Update: Evaluation and Management of Concussion in Sports

    March 2013

  3. Update: Determining Brain Death in Adults

    June 2010

  4. Child Neurology

  5. Practice Advisory: the Utility of EEG Theta/Beta Power Ratio in ADHD Diagnosis

    October 2016

  6. Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy

    February 2016

  7. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

    March 2015

  8. Summary of Evidence-based Guideline Update: Evaluation and Management of Concussion in Sports

    March 2013

  9. Update: Medical Treatment of Infantile Spasms

    June 2012

  10. Evidence Report: Genetic and Metabolic Testing on Children with Global Developmental Delay

    October 2011

  11. Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy

    January 2010

  12. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

  13. Diagnostic Assessment of the Child with Cerebral Palsy

    March 2004

  14. Evaluation of the Child with Global Developmental Delay

    February 2003

  15. Screening and Diagnosis of Autism

    August 2000

  16. Dementia

  17. Practice Guideline Update Summary: Mild Cognitive Impairment

    December 2017

  18. Diagnostic Accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease

    October 2012

  19. Update: Evaluation and Management of Driving Risk in Dementia

    April 2010

  20. Epilepsy

  21. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors

    April 2017

  22. Practice guideline: Use of fMRI in the presurgical evaluation of patients with epilepsy

    January 2017

  23. Evidence-based Guideline: Management of an Unprovoked First Seizure in Adults

    April 2015

  24. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  25. Update: Vagus Nerve Stimulation for the Treatment of Epilepsy

    August 2013

  26. Treatment of Parenchymal Neurocysticercosis

    April 2013

  27. Update: Medical Treatment of Infantile Spasms

    June 2012

  28. Antiepileptic Drug Selection for People with HIV/AIDS

    January 2012

  29. Update: Management issues for women with epilepsy-focus on pregnancy

    April 2009

  30. Evaluating an apparent unprovoked first seizure in adults

    November 2007

  31. Reassessment: Neuroimaging in the Emergency Patient Presenting with Seizure

    October 2007

  32. Use of Serum Prolactin in Diagnosing Epileptic Seizures

    September 2005

  33. Efficacy and Tolerability of the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy

    April 2004

  34. Efficacy and Tolerability of the New Antiepileptic Drugs II: Treatment of Refractory Epilepsy

    April 2004

  35. Headache

  36. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  37. Pharmacological Treatment of Migraine Headache in Children and Adolescents

    December 2004

  38. Movement Disorders

  39. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

  40. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  41. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  42. Treatment of Tardive Syndromes

    July 2013

  43. Pharmacologic Treatment of Chorea in Huntington Disease

    August 2012

  44. Update: Treatment of Essential Tremor

    October 2011

  45. Treatment of Nonmotor Symptoms of Parkinson Disease

    March 2010

  46. Botulinum Neurotoxin for the Treatment of Movement Disorders

    May 2008

  47. Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesias (without audio)

    October 2007

  48. Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease

    April 2006

  49. Treatment of Parkinson Disease with Motor Fluctuations and Dyskinesias (with audio)

    April 2006

    With audio.

  50. Neuroprotective Strategies and Alternative Therapies for Parkinson Disease

    April 2006

  51. Multiple Sclerosis

  52. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

  53. Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis

    March 2014

  54. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

  55. Neutralizing Antibodies to Interferon-beta: Assessment of their Clinical and Radiographic Impact

    March 2007

  56. Neuromuscular

  57. Practice Guideline Update Summary: Corticosteroid Treatment of Duchenne Muscular Dystrophy

    February 2016

  58. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Facioscapulohumeral Muscular Dystrophy

    July 2015

  59. Evidence-based Guideline Summary: Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

    March 2015

  60. Evidence-based Guideline Summary: Diagnosis and Treatment of Limb-girdle and Distal Dystrophies

    October 2014

  61. Intravenous Immunoglobulin in the Treatment of Neuromuscular Disorders

    March 2012

  62. Update: Intraoperative Spinal Monitoring with Somatosensory and Transcranial Electrical Motor Evoked Potentials

    February 2012

  63. Treatment of Painful Diabetic Neuropathy

    April 2011

  64. Update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies

    October 2009

  65. Evaluation of Distal Symmetric Polyneuropathy: Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy

    January 2009

  66. Immunotherapy for Guillain-Barre Syndrome

    September 2003

  67. Other

  68. Practice Guideline Summary: Treatment of Restless Legs Syndrome in Adults

    November 2016

  69. Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache

    April 2016

  70. Update: Steroids and Antivirals for Bell Palsy

    November 2012

  71. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

  72. The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia

    October 2008

  73. Therapies for Benign Paroxysmal Positional Vertigo

    May 2008

  74. Assessing Patients In A Neurology Practice For Risk Of Falls

    February 2008

  75. Treatment of Nervous System Lyme Disease

    July 2007

  76. Use of Epidural Steroid Injections to Treat Radicular Lumbosacral Pain

    March 2007

  77. Treatment of Postherpetic Neuralgia

    September 2004

  78. Stroke and Vascular Neurology

  79. Practice Advisory: Recurrent Stroke with Patent Foramen Ovale (Update of Practice Parameter)

    July 2016

  80. Summary of Evidence-based Guideline Update: Prevention of Stroke in Nonvalvular Atrial Fibrillation

    February 2014

  81. Periprocedural Management of Antithrombotic Medications in Patients with Ischemic Cerebrovascular Disease

    May 2013

  82. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

    January 2013

  83. Carotid Endarterectomy

    September 2005

  84. Recurrent Stroke in Patients with Patent Foramen Ovale and Atrial Septal Aneurysm

    April 2004

  85. Technology Assessments

  86. Practice guideline: Use of fMRI in the presurgical evaluation of patients with epilepsy

    January 2017

  87. Practice Advisory: the Utility of EEG Theta/Beta Power Ratio in ADHD Diagnosis

    October 2016

  88. Practice Guideline: Idiopathic Normal Pressure Hydrocephalus: Response to Shunting and Predictors of Response

    December 2015

  89. Update: Vagus Nerve Stimulation for the Treatment of Epilepsy

    August 2013

  90. Update: Intraoperative Spinal Monitoring with Somatosensory and Transcranial Electrical Motor Evoked Potentials

    February 2012

  91. Update: Plasmapheresis in Neurologic Disorders

    January 2011

  92. Botulinum Neurotoxin for the Treatment of Movement Disorders

    May 2008

  93. Use of Serum Prolactin in Diagnosing Epileptic Seizures

    September 2005

  94. Carotid Endarterectomy

    September 2005

  95. Transcranial Doppler Ultrasonography UPDATED

    May 2004

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer